Renaissance Technologies LLC Purchases 4,900 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Renaissance Technologies LLC raised its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 5.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 91,923 shares of the company's stock after purchasing an additional 4,900 shares during the quarter. Renaissance Technologies LLC owned 0.61% of U.S. Physical Therapy worth $8,154,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the stock. CBIZ Investment Advisory Services LLC lifted its holdings in shares of U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after acquiring an additional 122 shares during the period. Venturi Wealth Management LLC boosted its holdings in U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after purchasing an additional 704 shares in the last quarter. Pacer Advisors Inc. bought a new stake in shares of U.S. Physical Therapy in the 4th quarter valued at approximately $113,000. Mutual of America Capital Management LLC acquired a new position in shares of U.S. Physical Therapy in the 4th quarter worth approximately $203,000. Finally, KLP Kapitalforvaltning AS bought a new position in shares of U.S. Physical Therapy during the fourth quarter valued at $257,000.

Insider Transactions at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This trade represents a 19.44 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.00% of the company's stock.

U.S. Physical Therapy Trading Up 3.0 %

Shares of U.S. Physical Therapy stock traded up $2.04 during trading hours on Wednesday, hitting $69.91. The company's stock had a trading volume of 9,861 shares, compared to its average volume of 106,522. The stock has a 50 day moving average of $75.69 and a 200 day moving average of $84.59. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $108.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The company has a market capitalization of $1.06 billion, a PE ratio of 74.37, a price-to-earnings-growth ratio of 3.54 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. Analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 14th were paid a dividend of $0.45 per share. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a dividend yield of 2.57%. The ex-dividend date was Friday, March 14th. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 97.83%.

Analysts Set New Price Targets

Several research analysts have recently commented on USPH shares. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JMP Securities restated a "market outperform" rating and set a $113.00 target price on shares of U.S. Physical Therapy in a report on Tuesday. StockNews.com downgraded shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Thursday, April 17th. Barrington Research lowered their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. Finally, JPMorgan Chase & Co. dropped their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.